Abstract
Abstract
Background
Fatigue is a disabling symptom of multiple sclerosis. Its biological causes are still poorly understood. Several years ago, we proposed that fatigue might be the subjective representation of inflammatory processes. An important step for a straight-forward evaluation of our model would be to show that the level of fatigue is associated with vagal activation. The heart rate is under partial control of the vagus nerve. Using power spectrum analysis allows to separate, at least partly, sympathetic and parasympathetic impact on heart rate variability.
Methods
This narrative review summarizes the evidence for heart rate variability changes in MS patients, their relationship with fatigue and disease course. To do this, we conducted a literature search, including 45 articles relevant to the topic treated in this review.
Results
We illustrate that (1) inflammation leads to a change in cardiac behavior during acute and chronic phases, both in animals and in humans; (2) MS patients show changes of heart rate variability (HRV) that resemble those during acute and chronic inflammation due to multiple causes; (3) existing evidence favors a set of specific predictions about fatigue and parallel HRV changes; and (4) that MS-related brainstem lesions or neurological impairments do not completely explain HRV changes, leaving enough place for an explanatory relation between HRV and fatigue.
Discussion
We discuss the results of this review in relation to our model of fatigue and propose several observational and experimental studies that could be conducted to gain a better insight into whether fatigue and HRV can be interpreted as a common pathway, both reflecting activated autoimmune processes in MS patients.
Funder
Carl von Ossietzky Universität Oldenburg
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine
Reference94 articles.
1. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ (1994) The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 21(1):9–14. https://doi.org/10.1017/S0317167100048691
2. Fatigue guidelines development panel of the multiple sclerosis council for clinical practice guidelines (1998) Fatigue and Multiple Sclerosis. Evidence-Based Management Strategies for Fatigue in Multiple Sclerosis. Washington, DC: Paralyzed Veterans of America; 1998.
3. Fiest KM, Fisk JD, Patten SB et al (2016) Fatigue and comorbidities in multiple sclerosis. Int J MS Care 18(2):96–104. https://doi.org/10.7224/1537-2073.2015-070
4. Johansson S, Ytterberg C, Hillert J, Widén Holmqvist L, von Koch L (2008) A longitudinal study of variations in and predictors of fatigue in multiple sclerosis. J Neurol Neurosurg Psychiatry 79(4):454–457. https://doi.org/10.1136/jnnp.2007.121129
5. Mills RJ, Young CA (2011) The relationship between fatigue and other clinical features of multiple sclerosis. Mult Scler 17(5):604–612. https://doi.org/10.1177/1352458510392262
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comments on energy conservation treatments for MS-related fatigue and a new proposal;Journal of the Neurological Sciences;2024-06
2. Staunch the Age Related Decline into Dementia, Cancer, Autoimmunity (Long Covid), Obesity, and Other Diseases with a Prebiotic, Probiotic, Postbiotic Triple Play;Qeios;2024-04-09
3. Staunch the Age Related Decline into Dementia, Cancer, Autoimmunity (Long Covid), Obesity, and Other Diseases with a Prebiotic, Probiotic, Postbiotic Triple Play;Qeios;2024-04-02
4. Staunch the Age Related Decline into Dementia, Cancer, Autoimmunity (Long Covid), Obesity, and Other Diseases with a Prebiotic, Probiotic, Postbiotic Triple Play;Qeios;2024-04-02
5. Heart Rate Variability (HRV) serves as an objective correlate of distress and symptom burden in multiple sclerosis;International Journal of Clinical and Health Psychology;2024-04